I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Joseph Hagan Biography and Net Worth

CEO of Regulus Therapeutics

Mr. Hagan joined Regulus in January 2016 as Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer and was appointed to President and Chief Executive Officer in May 2017. Mr. Hagan’s career includes roles as the Executive Vice President, Chief Financial Officer and Chief Business Officer of Orexigen Therapeutics, Inc., Managing Director of Amgen Ventures and head of corporate development for Amgen Inc. Mr. Hagan has led numerous strategic and financing transactions including the acquisitions of Immunex and Tularik and the spinout of Novantrone and Relyspa, as well as many other business development efforts totaling over $15 billion in value. Before joining Amgen, Mr. Hagan spent five years in the bioengineering labs at Genzyme and Advanced Tissue Sciences. Mr. Hagan currently serves on the board of directors of Zosano Pharma, a publicly traded biotechnology company. He received an M.B.A. from Northeastern University and a B.S. in Physiology and Neuroscience from the University of California, San Diego

What is Joseph P. Hagan's net worth?: The estimated net worth of Joseph P. Hagan is at least $80,527.92 as of January 18th, 2024. Mr. Hagan owns 57,112 shares of Regulus Therapeutics stock worth more than $80,528 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Hagan may own. Additionally, Mr. Hagan receives an annual salary of $958,230.00 as CEO at Regulus Therapeutics. Learn More about Joseph P. Hagan's net worth.
How old is Joseph P. Hagan?: Mr. Hagan is currently 55 years old. There are 3 older executives and no younger executives at Regulus Therapeutics. Learn More on Joseph P. Hagan's age.
What is Joseph P. Hagan's salary?: As the CEO of Regulus Therapeutics Inc., Mr. Hagan earns $958,230.00 per year. Learn More on Joseph P. Hagan's salary.
How do I contact Joseph P. Hagan?: The corporate mailing address for Mr. Hagan and other Regulus Therapeutics executives is 10628 SCIENCE CENTER DRIVE SUITE 225, SAN DIEGO CA, 92121. Regulus Therapeutics can also be reached via phone at (858) 202-6300 and via email at [email protected]. Learn More on Joseph P. Hagan's contact information.
Has Joseph P. Hagan been buying or selling shares of Regulus Therapeutics?: Joseph P. Hagan has not been actively trading shares of Regulus Therapeutics within the last three months. Most recently, Joseph P. Hagan sold 14,580 shares of the business's stock in a transaction on Thursday, January 18th. The shares were sold at an average price of $1.19, for a transaction totalling $17,350.20. Following the completion of the sale, the chief executive officer now directly owns 57,112 shares of the company's stock, valued at $67,963.28. Learn More on Joseph P. Hagan's trading history.
Who are Regulus Therapeutics' active insiders?: Regulus Therapeutics' insider roster includes Christopher Aker (VP), Denis Drygin (Insider), and Joseph Hagan (CEO). Learn More on Regulus Therapeutics' active insiders.
Are insiders buying or selling shares of Regulus Therapeutics?: During the last twelve months, Regulus Therapeutics insiders bought shares 1 times. They purchased a total of 4,000 shares worth more than $7,280.00. During the last twelve months, insiders at the biopharmaceutical company sold shares 2 times. They sold a total of 20,048 shares worth more than $23,857.12. The most recent insider tranaction occured on July, 25th when Director Kathryn J Collier bought 4,000 shares worth more than $7,280.00. Insiders at Regulus Therapeutics own 4.4% of the company. Learn More about insider trades at Regulus Therapeutics.
Information on this page was last updated on 7/25/2024.

Joseph P. Hagan Insider Trading History at Regulus Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/18/2024	Sell	14,580	$1.19	$17,350.20	57,112
1/26/2022	Buy	100,000	$0.22	$22,000.00
5/17/2021	Sell	4,186	$0.89	$3,725.54	316,292
2/16/2021	Sell	4,144	$1.72	$7,127.68	485,756
8/14/2020	Sell	4,245	$0.60	$2,547.00	222,088
5/15/2020	Sell	4,426	$0.63	$2,788.38	226,333
2/18/2020	Sell	4,324	$0.83	$3,588.92	230,759
1/2/2020	Sell	8,345	$0.97	$8,094.65	235,083
11/14/2019	Sell	5,838	$0.64	$3,736.32	243,428
10/1/2019	Sell	8,743	$0.68	$5,945.24	249,266
8/15/2019	Sell	4,375	$0.55	$2,406.25
7/1/2019	Sell	5,783	$1.31	$7,575.73	262,384
5/16/2019	Sell	39,352	$1.22	$48,009.44	307,519
5/7/2019	Buy	33,194	$1.08	$35,849.52	64,542
4/1/2019	Sell	5,842	$0.98	$5,725.16	31,348
7/25/2017	Buy	219,780	$0.91	$199,999.80	241,297
3/3/2016	Buy	10,000	$7.19	$71,900.00	10,000

Joseph P. Hagan Buying and Selling Activity at Regulus Therapeutics

Regulus Therapeutics Company Overview

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $1.41

$1.30

$1.41

50 Day Range

MA: $1.54

$1.40

$1.82

2 Week Range

Now: $1.41

$1.08

$3.79

Volume

142,373 shs

Average Volume

1,231,964 shs

Market Capitalization

$92.36 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.63

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

Joseph Hagan Biography and Net Worth

What is Joseph P. Hagan's net worth?

How old is Joseph P. Hagan?

What is Joseph P. Hagan's salary?

How do I contact Joseph P. Hagan?

Has Joseph P. Hagan been buying or selling shares of Regulus Therapeutics?

Who are Regulus Therapeutics' active insiders?

Are insiders buying or selling shares of Regulus Therapeutics?